Cyclo Therapeutics, Inc. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CYTHW and buy or sell other stocks, ETFs, and their options commission-free!

About CYTHW

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. 

CEO
Scott Fine
CEOScott Fine
Employees
—
Employees—
Headquarters
Gainesville, Florida
HeadquartersGainesville, Florida
Founded
1990
Founded1990
Employees
—
Employees—

CYTHW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
3.99K
Average volume3.99K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.614
52 Week high$0.614
52 Week low
$0.0251
52 Week low$0.0251

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.